Irritable Bowel Syndrome

The new Rome IV criteria classify the functional bowel disorders into five distinct categories, including irritable bowel syndrome (IBS), functional constipation, functional diarrhea, functional abdominal bloating/distention, and unspecified functional bowel disorder. A new category for opioid-induced constipation, which is distinct from the functional bowel disorders, has been added.

Rome IV updates include more specific definitions and diagnostic criteria for functional gastroduodenal disorders such as functional dyspepsia, belching disorders, and nausea and vomiting disorders.

The Rome Foundation announced the release of updated and revised Rome IV diagnostic criteria for more than 20 different gastrointestinal disorders at DDW 2016.

Endoscopic retrograde cholangiopancreatography is a common procedure in adult patients but a recent study looked at whether the procedure was safe for younger patients and whether it provided the same level of efficacy.

Previously associated primarily with assessing blood alcohol level, breath tests can now aid in accurately distinguishing irritable bowel syndrome (IBS).

Anorexia nervosa, chronic fatigue syndrome, and irritable bowel syndrome (IBS) might not be the typical threesome, but these three conditions do share a common origin.

The field of gastroenterology is as wide as the the amount of the body that it covers. Because of this there are certain challenges doctors face whether they treat the entire gastrointestinal system or just specific parts.

For patients dealing with a variety of conditions fecal microbiota transplantation may be the best option for treatment. Explaining the procedure to patients can sometimes be a delicate conversation for doctors with good results so far.

Migraine and tension headaches potentially share genetic links with irritable bowel syndrome (IBS).

An inaugural trial using “smart†pills that measured intestinal gases inside a patient’s body showed favorable results and revealed ways in which fiber affects the gut.

Controlling the levels of specific gut bacteria could be useful in preventing severe diarrhea, according to findings published in the journal Microbiome.

Peppermint oil is the latest irritable bowel syndrome (IBS) treatment recommended by gastrointestinal specialists.

Intestinal transplantation can be the last resort for patients suffering from intestinal failure or other difficult conditions. Finding ways to make the procedure more effective can help more patients return to a higher quality of life.

Patients suffering from irritable bowel syndrome (IBS) can reduce their symptoms with the substance ebastine found in histamines used to treat hay fever.

Individualized medicine is a growing trend in health care and is making its way into the field of gastroenterology. Doctors are now looking to find treatments that not only work best for their patients but will also be easy for them to follow long term.

Adults afflicted with irritable bowel syndrome (IBS) and other gastrointestinal symptoms can benefit both short- and long-term from psychological therapies.

As a nonprofit organization OpenBiome is becoming one of the leaders in fecal microbiota transplantation technology and also working to boost other areas of public health as well.

Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.

People suffering from irritable bowel syndrome (IBS) also often have lower levels of vitamin D.

Colonoscopy patients often don’t accurately recall pertinent details of their exam over time, according to study results presented at the 2015 Clinical Congress of the American College of Surgeons in October.

Global pharmaceutical company Allergan announced today the availability by prescription of Viberzi (eluxadoline), their first-in-class treatment for adult patients suffering from irritable bowel syndrome with diarrhea (IBS-D).

Treatment for irritable bowel syndrome (IBS) is significantly more expensive when treated in secondary care settings than it is when treated in primary care settings -- without a corresponding increase in treatment effectiveness.

New research shows that ramosetron reduces symptoms of irritable bowel syndrome (IBS) and increases stool consistency and quality of life in women.

Changes in gut bacterial growth rates may be linked to onset of diseases, such as type 2 diabetes or irritable bowel syndrome, for example, according to research published in the journal Science.

Some microbes are more associated with specific irritable bowel disease symptoms than others, researchers reporting at the American College of Gastroenterology Scientic Meeting reported.

Treatments for irritable bowel system are proliferating. In addition to new drugs, more drug candidates are entering the approval pipeline. Even as physicians await these new products, their patients are getting into the act by doing internet research and other reading-and tv watching-that has them trying unproven remedies with mixed results.

IBS patients are great, because many times they come to you frustrated they don't have a "diagnosis".

Whether patients have irritable bowel syndrome or inflammatory bowel disease what matters to them most is getting the correct diagnosis and treatment as quickly as possible.

The US Food and Drug Association (FDA) granted approval for eluxadoline (Viberzi) and rifaximin (Xifaxan), to treat irritable bowel syndrome with diarrhea (IBS-D) in adult men and women.

Some intestinal bacteria cause more pain than others in patients with irritable bowel syndrome, according to study results reported by a team of researchers from North Carolina.